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Abstract  
Recovery of multispecies oral biofilms is investigated following treatment by 
chlorhexidine gluconate (CHX), iodine-potassium iodide (IPI) and Sodium 
hypochlorite (NaOCl) both experimentally and theoretically. Experimentally, biofilms 
taken from two donors were exposed to the three antibacterial solutions (irrigants) for 
10 minutes, respectively. We observe that (a) live bacterial cell ratios decline for a 
week after the exposure and the trend reverses beyond a week; after fifteen weeks,  
live bacterial cell ratios in biofilms fully return to their pretreatment levels; (b) NaOCl 
is shown as the strongest antibacterial agent for the oral biofilms; (c) multispecies oral 
biofilms from different donors showed no difference in their susceptibility to all the 
bacterial solutions. Guided by the experiment, a mathematical model for biofilm 
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dynamics is developed, accounting for multiple bacterial phenotypes, quorum sensing, 
and growth factor proteins, to describe the nonlinear time evolutionary behavior of the 
biofilms. The model captures time evolutionary dynamics of biofilms before and after 
antibacterial treatment very well. It reveals the crucial role played by quorum sensing 
molecules and growth factors in biofilm recovery and verifies that the source of 
biofilms has a minimal to their recovery. The model is also applied to describe the 
state of biofilms of various ages treated by CHX, IPI and NaOCl, taken from different 
donors. Good agreement with experimental data predicted by the model is obtained as 
well, confirming its applicability to modeling biofilm dynamics in general.   
 
Keywords: Biofilms, Antibacterial treatment, Mathematical models, Biofilm recovery 
 
Introduction 
 
Success in endodontics is achieved by a combination of host and treatment factors 
that contribute to the management of the infection, prevention and healing of 
periapical pathosis 
1,2
. Instrumentation is important in removing microbes from the 
root canals, but after mechanical instrumentation alone, canals often remain heavily 
infected. Instrumentation creates the space necessary for effective irrigation, which 
plays the key role in further reducing the number of residual microbes. Irrigating 
solutions with a strong antibacterial effect are necessary. However, currently available 
irrigants face great challenges in eliminating all the biofilms from the root canals. The 
biofilms are results of the microbial growth, where dynamic communities of 
interacting sessile cells are irreversibly attached to a solid substratum as well as next 
to each other through a network of extracellular polymeric substances (EPS). 
Microbial communities growing in biofilms are very difficult to be eradicated with 
antibacterial agents 
3,4
. Microorganisms in mature biofilms can be extremely resistant 
to antibacterial agents for reasons that have yet been fully understood 
5,6
. 
 
There are several antibacterial solutions or irrigants available in the market 
currently. Sodium hypochlorite (NaOCl) is the most popular and important irrigating 
solution 
7
. In water, NaOCl ionizes into sodium ion, Na+, and hypochlorite ion, OCl-, 
establishing equilibrium with hypochlorous acid (HOCl). Hypochlorous acid is 
responsible for its antibacterial activity; OCl- is less effective than undissolved HOCl. 
NaOCl is commonly used in concentrations ranging from 0.5% to 6%. It is the only 
irrigant in endodontics that can dissolve organic tissue, including the organic part of 
the smear layer. Another irrigant, Chlorhexidine digluconate (CHX), is widely used in 
disinfection in dentistry because of its antibacterial activity 
8-10
. It has gained 
considerable popularity in endodontics as an irrigating solution and as an intra-canal 
medicament. However, CHX has no tissue dissolving capability and therefore it 
cannot replace sodium hypochlorite. CHX is membrane permeable and attacks the 
bacterial cytoplasmic inner membrane or the yeast plasma membrane. In high 
concentrations, CHX causes coagulation of intracellular components 
11
. One of the 
reasons for the popularity of CHX is its substantivity (i.e. continued antibacterial 
effect), which stems from its ability to bind to hard tissue and maintain antibacterial 
activity. Iodine compounds are among the oldest disinfectants still actively used. They 
are best known for their use on surfaces, skin, and operation fields. Iodine is less 
reactive than the chlorine in hypochlorite. However, it kills rapidly and has 
bactericidal, fungicidal, tuberculocidal, virucidal, and even sporicidal activity 
12
. 
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Iodine penetrates rapidly into the microorganisms and causes cell death by attacking 
proteins, nucleotides, and other key subcellular components of the cell 
12,13
.
 
 
Oral biofilm recovery after treatment by two different CHX irrigants for 1, 3, 10, 
minutes respectively was recently studied by Shen et al 
14
. Results from the study 
showed that biofilms started recovering after two weeks, and then fully returned to the 
pre-treatment level after eight weeks. However, because all the biofilms in that study 
were grown from plaque bacteria obtained from one donor and only the CHX solution 
was tested, it is insufficient to evaluate whether the results can be generalized or if 
they represent the behavior of that particular biofilm exposed to CHX only. Therefore, 
the experimental aim of this study is to assess the effect of the source of biofilm 
bacteria and the type of antibacterial agents on biofilm recovery after exposure to 
different antibacterial agents. 
 
In this paper, we investigate recovery of multispecies oral biofilms from two 
donors following CHX, iodine-potassium iodide (IPI) and sodium hypochlorite 
(NaOCl) treatments, respectively. Before the antibacterial treatment, the biofilms are 
allowed to grow for three weeks. After 10 minutes’ treatment by the antibacterial 
agents, a large number of bacteria in the biofilms continue to die up to one week and 
the bacterial dying rate reduces beyond one week. The full recovery of the biofilms 
needs about 15 weeks afterwards. Interestingly, recovery of biofilms from different 
donors shows similar dynamics after the treatment. 
 
To fully understand the mechanism of biofilm recovery, a quantitative model in the 
form of dynamical systems is developed, which accounts for the regulation of growth 
factor proteins and quorum sensing molecules to bacterial growth and EPS regulation 
in addition to bacterial cell interactions and their response to antibacterial treatment. 
The model captures time evolutionary dynamics of the biofilms after antibacterial 
treatment. The model is then applied to another experiment on biofilm’s susceptibility 
to three antibacterial agents right after antibacterial treatment to confirm its validity in 
modeling biofilm dynamics for biofilms of various ages right after the treatment 
6
. 
Using the model, we can explore crucial roles played by the EPS, quorum sensing 
molecules and growth factor proteins on biofilm dynamics before and after the 
antibacterial treatment.  This model uses a simplified description of the oral bacterial 
biofilm and performs as good as or even better than the multispecies model given in 
14
, 
making it a robust, quantitative model for study biofilm dynamics.  
 
Materials and Methods 
 
Experiment Development 
 
Biofilm specimen preparation and treatment 
 
Sterile hydroxyapatite (HA) discs (Clarkson Chromatography Products, 
Williamsport, PA) were used as the biofilm substrate. The HA discs were coated with 
bovine dermal type I collagen (10 μg/mL collagen in 0.012 N HCl in water) 
(Cohesion, Palo Alto, CA) as described in [16, 17]. Supragingival and subgingival 
plaque was collected from 2 adult volunteers, and suspended in brain heart infusion 
broth (BHI, Becton Dickinson, Sparks, MD, USA). For each plaque donor a separate 
batch of biofilms was grown. Coated HA disks were placed in the wells of a 24-well 
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tissue culture plate containing 1.80 mL BHI, and 0.2 mL plaque suspension was 
added to each well. The disks were incubated in BHI under anaerobic conditions 
(Bactron300 Shellab Anaerobic Chamber; Sheldon Manufacturing, Inc., Cornelius, 
OR) at 37˚C for 3 weeks. Fresh medium was changed once per week. 
 
After 3 weeks of anaerobic incubation in BHI broth, specimens were rinsed twice 
in 1 mL physiological saline for 1 minute and immersed in 1 mL 1% NaOCl, 0.2/0.4% 
iodine-potassium iodide (IPI), or 2% CHX for 10 minutes. One percent NaOCl was 
freshly prepared by diluting the 5.25% stock solution (The Clorox Company, Canada) 
in distilled water, 0.2/0.4% IPI was prepared by mixing 0.2 g iodine (Sigma Chemical 
Co, St Louis, MO) in 0.4 g potassium iodide (Sigma Chemical Co) and adding 
distilled water to a 100-mL volume, and 2% CHX was freshly prepared by diluting in 
sterile water from 20% stock solution (Sigma Chemical Co). Control specimens, after 
rinsing in saline, were exposed to 1 mL sterile commercialized water for 10 minutes.  
 
Examination with CLSM 
 
Samples for confocal laser scanning microscopy (CLSM) for viability staining 
were collected immediately after 1, 3, 8, 11 and 15 weeks after the exposure to the 
medicaments. Specimens tested with saline for corresponding time periods were used 
as controls. For all specimens, the fresh BHI broth was changed once a week. 
 
 
Two biofilm discs were examined for each time period. The biofilms discs for 
CLSM imaging were rinsed in 0.85% physiological saline for 1 minutes to remove the 
culture broth. They were then stained with a bacterial viability stain (LIVE/DEAD 
Baclight Kit; Thermo Fisher Scientific, Waltham, MA) and scanned with CLSM as 
described previously 
14-17
. Three-dimensional volume stacks were constructed with 
Imaris 7.2 software (Bitplane Inc, St Paul, MN), and the total volume of red (dead 
bacteria) and green (live bacteria) fluorescence was measured. The proportion of dead 
bacteria was calculated from the proportion of red fluorescence to the total of green 
and red fluorescence. The results were analyzed using Univariate ANOVA followed 
by post hoc analysis at a significance level of P < 0.05. 
 
Mathematical Model Formulation 
 
Model assumptions 
 
The response of biofilms to antibacterial treatment in experiments reveals that the 
biofilm recovery process after antibacterial treatment is highly nonlinear and sensitive 
to antibacterial agents applied. A quantitative model would be useful to describe 
dynamics in the process and to identify influential factors (or biomarkers) dictating 
biofilm recovery after the treatment. In this model, we coarse-grain bacteria into two 
basic types: the live and the dead bacteria. Their volume fractions are denoted, 
respectively, as L and D. Besides the bacteria, the volume fractions of the EPS and 
solvent are also non-negligible and are denoted by E and T, respectively. There exist 
functional components in the biofilm that affect the growth/decay and dynamics of the 
biofilm. These include quorum sensing (QS) molecules, growth factor (GF) proteins 
and antibacterial agents in a minimal set. Since they normally occupy negligibly small 
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volume fractions in the biofilm, their volume fractions are therefore ignored in this 
model for simplicity. Under these assumptions, we have 
 𝐿 + 𝐷 + 𝐸 + 𝑇 = 1. (1) 
 
Previous experiments showed that biofilms would be mature at about the third 
week, and both the previous and recent experimental evidence showed that mature 
biofilms would undergo a long period to recover after antibacterial treatment. To 
model the nonlinear process of biofilm recovery, we introduce a functional 
component named growth factor in this model, to regulate cell proliferation. This is a 
proxy for perhaps a set of functional proteins. Identifying the growth factor or growth 
factors would be a challenging experimental endeavor in the future that we strongly 
recommend through this quantitative study. Here, we assume the concentration of 
nutrient during the process is constant for simplicity. The concentration of QS 
molecules, antibacterial agents and growth factors are denoted as H, A and Q, 
respectively.  
Dynamical equations of bacteria 
The birth and death of bacteria are dictated by several factors including bacterial 
proliferation, the natural cell death and the killing by antibacterial agents (A). The 
proliferation of live bacteria (L) is limited by nutrient and the carrying capacity (Lmax) 
of the environment, and also affected by growth factors (Q). In this model, we assume 
the live bacteria proliferate following a logistic model with the growth rate regulated 
by the growth factor while the cell death is governed by the natural cause and the 
antibacterial killing. We use a causality diagram to show the mechanisms as follows:  
 𝐿
(𝑐2,𝑄,𝐿)
→    2𝐿, (2) 
   
 𝐿
(𝑟𝑏𝑠,𝑐3𝛾𝐴)
→       𝐷, (3) 
where 
2
2 2 2
q
Q
Q
c
k
is the proliferation rate of live cells,  𝑟𝑏𝑠 is the natural death rate of 
live bacteria and 𝑐3𝛾𝐴 the antibacterial killing rate. The reactive equation for live 
bacteria is then given by    
 
𝑑𝐿
𝑑𝑡
= 𝑐2
𝑄2
𝑄2 + 𝑘𝑞2
(1 −
𝐿
𝐿𝑚𝑎𝑥
) 𝐿 − 𝑟𝑏𝑠𝐿 − 𝑐3𝛾𝐴𝐿, (4) 
where, 𝑘𝑞 is a constant in the Hill function and 𝛾 is a relaxation parameter to 
represent the effect of spatial diffusion in the spatially homogeneous system, which is 
proposed in the Hinson model
18
 as follows:   
 𝛾 =
1
𝑇+
𝐸
𝐷𝑝𝑟
2(𝑇+𝐸)
2+(𝐿+𝐷)
, (5) 
where Dpr  is a parameter representing the relative diffusivity of EPS. In this 
approximation, spatial diffusion is effectively replaced in a uniform decay in space, 
i.e, the homogeneous spatial decay is used as a proxy for heterogeneous diffusion in 
space.  
The natural and killing death of live bacteria contributes to the increase in the 
population of the dead bacteria. The dead bacteria (D) can also disintegrate to shed 
their surface-attached EPS. So, we assume the dead bacteria eventually disintegrate 
into EPS (E) and solvent (T): 
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 𝐷
(𝑟𝑑𝑝,𝑘13,𝐴)
→       𝐸 + 𝑇. (6) 
By assuming that the antibacterial agent can in fact slows down the degradation of 
dead cells, we arrive at the following reactive equation for the rate of change in dead 
bacterial volume fraction:   
 
𝑑𝐷
𝑑𝑡
= 𝑟𝑏𝑠𝐿 + 𝑐3𝛾𝐴𝐿 − 𝑟𝑑𝑝
𝑘13
𝑘13 + 𝐴
𝐷, (7) 
where 𝑟𝑑𝑝 is the break down rate of dead bacteria at the absence of antibacterial 
agents, k13 is a constant. The first two terms are related to the death of live bacteria 
cells due to the natural cause and antibacterial effect, respectively, while the last term 
represents the degradation of dead bacteria into EPS and solvent components due to 
cell lysis as well as the antibacterial effect. Without being treated by antibacterial 
agents, the dead cell degrades with a constant rate rdp. With the stress imposed by the 
antibacterial effect on the biofilm,  we surmise the degradation of dead cells would 
be slowed down. This assumption on the degradation of dead cells is based on the 
assumption that antibacterial treatment disrupts the natural process of a cell cycle, 
delaying their disintegration into other biofilm components. This seemingly arbitrary 
assumption is in fact strongly supported by our model calibration in that the other 
assumptions on the decay rate would make the model less faithful to the experimental 
data. We therefore believe the assumption made is credible in this model. 
Reactive equation of EPS production 
The production of EPS (E) is affected by quorum-sensing molecules (H), live 
bacterial (L) and ultimately EPS saturation at its carrying capacity (Emax). The 
biochemical process can be described by the causality diagram:  
 𝐿
(𝑐5,𝐻,𝐸)
→     𝐿 + 𝐸, (8) 
where 𝑐5
𝐻2
𝐻2+𝑘9
2 (1 −
𝐸
𝐸𝑚𝑎𝑥
) is the EPS production rate. The reactive equation for the 
rate of change in EPS volume fraction is then given as follows:  
 
𝑑𝐸
𝑑𝑡
= (𝑐5𝐿
𝐻2
𝐻2 + 𝑘9
2 + 𝑟𝑑𝑝
𝑘13
𝑘13 + 𝐴
𝐷) (1 −
𝐸
𝐸𝑚𝑎𝑥
), (9) 
where the first part represents the gain of EPS due to live bacteria, the second part 
comes from the degradation of the dead bacteria, and  𝑘9 is a constant in the Hill 
function for the QS concentration dominated production rate.  
Dynamical equations of the functional components 
The natural degradation of the antibacterial agents, loss in effectiveness, their 
diffusion and reaction with cells are considered in this quantitative model. The 
degradation process of antibacterial agents is modeled like this:  
 
 
𝑑𝐴
𝑑𝑡
= −𝑐8𝐴𝐿 − 𝑟𝑎𝐴, (10) 
where 8c  is the killing rate of the bacteria by antibacterial agents and ar  is the 
degradation of antibacterial agents in the solution. 
   The production of QS molecules (H) and growth factors (Q) are related to the 
volume fraction of live bacteria (L) while, in the meantime, can saturate at their 
carrying capacities Hmax and Qmax. For simplicity, we assume the increase in QS 
molecules (H) is also regulated by the growth factor (Q) in the form of a Hill function 
in this model. The mechanisms are summarized as follows:  
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 𝐿
(𝑐𝑎,𝑄,𝐿,𝐻)
→      𝐿 + 𝐻, (11) 
 
 𝐿
(𝑐𝑞,𝐿,𝑄)
→    𝐿 + 𝑄, (12) 
where 𝑐𝑎,𝑐𝑞 are pre-factors for the QS molecules and growth factors, respectively. 
We propose the following reactive equations to quantify the mechanisms:  
 
 
𝑑𝐻
𝑑𝑡
= 𝑐𝑎
𝑄2
𝑄2 + 𝑘𝑞2
𝐿 (1 −
𝐻
𝐻𝑚𝑎𝑥
), 
 
(13) 
 
 
𝑑𝑄
𝑑𝑡
= 𝑐𝑞𝐿 (1 −
𝑄
𝑄𝑚𝑎𝑥
), (14) 
where 𝐻𝑚𝑎𝑥,𝑄𝑚𝑎𝑥  are carrying capacities for QS molecules and growth factors, 
respectively.  
Summary of the governing equations 
The coupled dynamical equations of the biofilm in its dimensionless form are 
summarized as follows  
 
 
 
 
 
𝑑𝐿
𝑑𝑡
= 𝑐2
𝑄2
𝑄2 + 𝑘𝑞2
(1 −
𝐿
𝐿𝑚𝑎𝑥
)𝐿 − 𝑟𝑏𝑠𝐿 − 𝑐3𝛾𝐴𝐿, 
 
(15) 
 
 
𝑑𝐷
𝑑𝑡
= 𝑟𝑏𝑠𝐿 + 𝑐3𝛾𝐴𝐿 − 𝑟𝑑𝑝
𝑘13
𝑘13 + 𝐴
𝐷, (16) 
 
 
𝑑𝐸
𝑑𝑡
= (𝑐5𝐿
𝐻2
𝐻2 + 𝑘9
2 + 𝑟𝑑𝑝
𝑘13
𝑘13 + 𝐴
𝐷) (1 −
𝐸
𝐸𝑚𝑎𝑥
), (17) 
 
 
𝑑𝐴
𝑑𝑡
= −𝑐8𝐴𝐿 − 𝑟𝑎𝐴, (18) 
 
 
𝑑𝐻
𝑑𝑡
= 𝑐𝑎
𝑄2
𝑄2 + 𝑘𝑞2
𝐿 (1 −
𝐻
𝐻𝑚𝑎𝑥
), (19) 
 
 
𝑑𝑄
𝑑𝑡
= 𝑐𝑞𝐿 (1 −
𝑄
𝑄𝑚𝑎𝑥
), (20) 
where  
 𝐿 + 𝐷 + 𝐸 + 𝑇 = 1, (21) 
 
 
𝛾 =
1
𝑇 +
𝐸
𝐷𝑝𝑟
2(𝑇 + 𝐸)
2 + (𝐿 + 𝐷)
. 
(22) 
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The causality relationships used to derive the dynamical equations are summarized in 
a computational graph in Fig 1. The nondimensionalization of the equations and 
variables is given in the appendix. 
We solve this coupled dynamical system using ode45 solver in Matlab. Some 
model parameters are taken from the literature while others are calibrated against the 
experiments reported in this paper and in a previous publication [22]. 
 
Figure 1.  Computational graph of the mathematical model. L, D, E, T , A, Q and H 
are volume fractions or concentrations of live bacteria, dead bacteria, EPS, solvent, 
antibacterial agents, growth factors and QS molecules, respectively.   means the 
degradation of the antibacterial agents. In this directed graph, causal relationships 
among the components are labelled with arrows and related rates.  
 
Calibration of Model Parameters 
The proposed model given in (15)~(22) is a mechanistic model based on a few 
fundamental mechanisms and experimentally informed assumptions.  Several model 
parameters need to be calibrated against specific antibacterial agents and biofilm 
specimen from different donors. We use the following strategy to calibrate the 
parameters.  
 
1. We first calibrate model parameters independent of antibacterial agents 
using the control group. Since there is no antibacterial agent in the control 
group, we set A=0. In addition, since the biofilm is fairly mature in the 
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control group, we assume the volume fraction of live bacteria, dead bacteria 
and EPS in the control group have reached their steady state Lss , Dss , after 
three weeks. So we set 
 
 
𝑟𝑏𝑠𝐿
𝑠𝑠 − 𝑟𝑑𝑝𝐷
𝑠𝑠 = 0. (23) 
 
It follows that 
 
 
 𝑟𝑏𝑠 = 𝑟𝑑𝑝
𝐷𝑠𝑠
𝐿𝑠𝑠
. (24) 
 
Note that rdp/ (rbs + rdp)= L
ss
/(L
ss
+D
ss
) and the live to total cell ratio is 
measured in the control group. So, we obtain the ratio of rdp and rbs. 
 
 
2.  We then calibrate model parameters against the control group without the 
antibacterial effect. The parameters related to antibacterial agents are 
calibrated the last. After we obtain the ratio of rdp and rbs , we use a 
bisection method to fit the parameters sequentially. We begin with a 
prescribed range of parameters resulting from the nondimensionalization 
and proceed until we get the best fit possible. Specifically, we set an 
upper limit for each parameter firstly. Then, we use the bisection method 
to search for the best fit of the model solution to the experimental data for 
the parameters one-by-one. Before finding the next parameter value using 
the bisection method, all the already obtained parameter values will be 
adjusted accordingly as the next parameter is fitted slightly. This method 
has been used to produce all the parameter values we use throughout this 
study. 
 
We note that biofilms from different donors may be different. So, their responses 
to antibacterial treatment can also vary. Once the origin of the biofilm changes, we 
recalibrate the model parameters. As the result of the model calibration, we find that 
biofilm recoveries taken from different donors are similar, which indicates that there 
exist an invariant set of parameter values in the model that are insensitive to donors in 
biofilm recovery (see Table 2). 
 
As a result, we classify the model parameters into three classes based on parameter 
calibration results: (I) donor-independent parameters; (II) donor-dependent 
parameters; (III) antibacterial agent specific parameters. Our study indicates that 
fluctuations of the parameters in group II on the donors are small. This result supports 
a single model for all donors’ approach that we are taking in this study. 
  
Classes I II III 
Model 
parameters 
Hmax c2 c3 
Qmax cq c8 
c5 rbs ra 
ca rdp k13 
c9 Lmax Dpr 
kq Emax  
10 
 
 
Table 1. Classification of model parameters: (I) donor-independent parameters; (II) 
donor-dependent parameters; (III) antibacterial agent specific parameters 
 
 
Results  
 
Experimental results  
 
A total of 96 HA biofilm discs and 480 scanned areas were analyzed. The biofilms 
were treated for 10 mins by three antibacterial agents three weeks after they were 
taken from donors. Immediately after treatment, the viability profile of the biofilm 
population changed, demonstrating an increased number of dead cells (Fig 2). This 
occurred in all groups, but was more prominent in the biofilms treated with 1% 
NaOCl. NaOCl showed higher levels of bactericidal activity compared to 2% CHX 
and 0.2/0.4% IPI (P < 0.05; Fig 2). Cell death in the biofilms continued to intensifies 
for up to one week after exposure to all antibacterial solutions (P < 0.001). The 
viability of the bacterial population increased three weeks after treatment, although  
biofilms began to recover one week after treatment (Fig 2). Eight weeks after 
treatment, the proportion of viable bacteria almost reached that of the pre-treatment 
level in CHX groups, but was somewhat less in IPI and NaOCl treated groups (Fig 2). 
Eleven weeks after the treatment, bacterial viability in all groups returned to the 
pre-treatment level (expressed as percentages). 
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Figure 2. Recovery of bacteria in biofilms taken from donors after 10 min treatment using three antibacterial solutions. The effectiveness of 
bacterial killing ranks from NaCO1 to IPI to CHX. 
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Numerical Results 
The percentage of live bacteria dropped immediately after antibacterial treatment. 
Since the bacteria were treated at the end of the third week of biofilm growth, after 
taken from the donors, and the duration of treatment was 10 mins, we set the moment 
right after the treatment as time 0 in the dynamical simulations of the model. The 
percentage recovered to its pretreatment value at the end of the next 15 weeks. The 
numerical solution of the dynamical model all fall within the error bar of the 
experimental data, giving a reasonable prediction. As shown in Fig 3, the ability of 
NaOCl to kill bacteria is much stronger than that of CHX and IPI. So, the biofilm 
treated by NaOC1 recovers the most slowly.  
 
In Fig 5(A&B), we plot the solution of the model prediction for donor 1. We notice 
that the decline of the live bacterial ratio initially after antibacterial treatment is to a 
large extent due to the rapid increase in the number of dead bacteria. When the 
number of dead bacteria starts to decline after a week, the ratio of live bacterial begins 
to increase as well.   
 
Figure 3. Time evolution of biofilm recovery for donor1 (A) and donor2 (B). The 
biofilms were taken from donor 1 and donor 2, respectively, and treated by three 
antibacterial solutions for 10 mins. At the time of antibacterial treatment, the biofilms 
had already grown for three weeks.  The results indicate that NaOCl is the most 
effective antibacterial agent among the three and  IPI shows slightly higher 
effectiveness than CHX  for both donors.  The ratio of live bacteria was calculated 
using L/(L+D) and measured in the experiments, which are then used in parameter 
calibration. The smooth curves are the model predictions and the points with error 
bars are experimentally measured values. 
 
Symbol Units Donor 1 Donor 2 
CHX IPI NaOCl CHX IPI NaOCl 
Hmax kg/m
3
 8.24e-3 8.24e-3 8.24e-3 8.24e-3 8.24e-3 8.24e-3 
Qmax kg/m
3
 2.47e-3 2.47e-3 2.47e-3 2.47e-3 2.47e-3 2.47e-3 
c2 s
-1
 3e-6 3e-6 3e-6 3e-6 3e-6 3e-6 
*c3 s
-1
m
3
/ 
kg   
2.06e-1
 
1.5e-1 4.5e-1 1.76e-1 1.40e-1 5.81e-1 
c5 s
-1
 9.9e-1 9.9e-1 9.9e-1 9.9e-1 9.9e-1 9.9e-1 
*c8 s
-1
 2e-5 2e-5 9e-6 2e-5 1e-5 1e-5 
ca kg/m
3
 8.24e-9 8.24e-9 8.24e-9  8.24e-9 8.24e-9 8.24e-9 
cq kg/m
3
 1.65e-8 1.65e-8 1.65e-8 1.65e-8 1.65e-8 1.65e-8 
*ra s
-1
 1.8e-7 2e-7 3e-7 8e-8 2.4e-7 2.7e-7 
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rbs s
-1
 1.6e-7 1.6e-7 1.6e-7 1.8e-7 1.8e-7 1.8e-7 
rdp s
-1
 2e-6 2e-6 2e-6 2e-6 2e-6 2e-6 
*Dpr  1.6e-2 5e-2 6e-3 2.66e-2 7e-2 3.5e-3 
k9 kg/m
3
 6.59e-3 6.59e-3 6.59e-3 6.59e-3 6.59e-3 6.59e-3 
*k13 kg/m
3
 2.88e-8 1.48e-8 1.48e-8 1.24e-8 1.24e-8 1.48e-8 
kq kg/m
3
 2.47e-3 2.47e-3 2.47e-3 2.47e-3 2.47e-3 2.47e-3 
Lmax   8e-2 8e-2 8e-2 8e-2 8e-2 8e-2 
Emax  1.2e-2 1.2e-2 1.2e-2 1.2e-2 1.2e-2 1.2e-2 
*The 
leaked 
agents 
kg/m
3
 1.24e-6 9.89e-7 1.3e-7 1.03e-7 1.25e-7 1.43e-7 
 
Table 2. The model parameter values calibrated using the data from the control group 
and the treated group. The starred entries indicate different model parameters for 
different donors and the others are identical to all donors indicating they are 
insensitive to different donors. The characteristic time scale t0=1s and the 
characteristic concentration scale C=8.24e-3kg/m
3
are used 
19
.  
 
Model predictions on responses of biofilms of various ages to antibacterial 
treatment 
We apply the mathematical model to another set of experimental data reported by 
Stojicic et al. in 
6
. Here, we calibrate the model parameters to fit responses of various 
aged biofilms to the three antibacterial agents following the procedure alluded to 
earlier. Stojicic et al investigated the dynamic process of biofilms of various ages 
varying from the initial attachment of planktonic bacteria to a mature, structurally 
complex biofilm (0~8 weeks). The biofilms of various ages up to 8 weeks were 
treated by 2% CHX (Fig 4A), 0.2/0.4% IPI (Fig 4B) and 1% NaOCl (Fig 4C) for 1 
min and 3 mins, respectively. Their work showed significant difference among the 
killing ratios of all tested antibacterial solutions in young (less than 2 weeks old) and 
mature (3 weeks or older) biofilms in all treatments. We use the quantitative model to 
simulate biofilm growth from the beginning to the moment right after the antibacterial 
treatment and report the post treatment result. The model fits very well to the 
experimental data following the parameter calibration procedure alluded to earlier. In 
addition, we notice that the recalibrated parameter values in the model do not differ 
much from the other set of parameter values calibrated on a data set of completely 
different biofilm experiments, indicating the model indeed captures the essence in 
biofilm growth dynamics. Both experiments and model predictions show that biofilms 
become mature after about three weeks (Fig 4). For mature biofilms, the consequence 
of antibacterial treatment becomes insensitive to the age of the biofilms. For younger 
biofilms the killing of live bacteria in treated biofilms is significant compared with the 
mature biofilms (see Fig 5 C&D). For mature biofilms, we observe that the EPS 
concentration is high at the time of treatment (Fig 5C). In the quantitative study, the 
dimensionless concentration of antibacterial agents we use to briefly treat the biofilms 
is chosen as 1 and initial volume fraction of live bacteria taken from the donors is 
chosen as 0.05. The experimental data are taken from the paper 
6
.   
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Figure 4 The responses of different aged biofilms to 1 min and 3 min CHX 
treatment (A), 1 min and 3 min IPI treatment (B) and 1 min and 3 min NaOCl 
treatment (C), respectively. The time axis here indicates the age of the biofilm. The 
results presented are the solutions of the quantitative model at different ages right 
after they are treated by antibacterial agents for 1 min and 3 mins, respectively. For 
example, the curve plotted at t=21 days are the solutions of the model at 21days+1 
15 
 
min (dashed) and 21days+3min (dotted) with the antibacterial agent applied to the 
biofilm at the 21st day for 1 min and 3 mins, respectively.   
 
Symbol Units CHX IPI NaOCl 
Hmax kg/m
3
 8.24e-3 8.24e-3 8.24e-3 
Qmax kg/m
3
 2.47e-3 2.47e-3 2.47e-3 
c2 s
-1
 3e-4 3e-4 3e-4 
*c3 s
-1
m
3
/ kg   1.20 2.18e-1 9.47e-1 
c5 s
-1
 9.9e-1 9.9e-1 9.9e-1 
c8 s
-1
 1e-2 1e-2 1e-1 
ca kg/m
3
 8.24e-9 8.24e-9 8.24e-9 
cq kg/m
3
 4.94e-9 4.94e-9 4.94e-9 
*ra s
-1
 1.3e-2 1.6e-2 4e-3 
rbs s
-1
 1.6e-7 1.6e-7 1.6e-7 
rdp s
-1
 5e-6 5e-6 5e-6 
*Dpr  4.8e-2 2.66e-2 1.66e-3 
k9 kg/m
3
 6.59e-3 6.59e-3 6.59e-3 
k13 kg/m
3
 1.48e-8 1.48e-8 1.48e-8 
kq kg/m
3
 2.47e-3 2.47e-3 2.47e-3 
Lmax   1.2e-1 1.2e-1 1.2e-1 
Emax  2.2e-1 2.2e-1 2.2e-1 
                     
Table 3. The model parameter values calibrated based on the response of different 
aged biofilms to antibacterial treatment. The starred entries indicate the parameters 
are sensitive to antibacterial agents in the model while the others are insensitive to 
antibacterial agents. The characteristic time scale t0=1s and the characteristic 
concentration scale C=8.24e-3 kg/m
3 
are used 
19
.   
Role of QS molecules and the growth factor in biofilm dynamics 
Since the recovery curves are the same qualitatively for different antibacterial 
agents and donors, we only show the time evolution of volume fractions of live 
bacteria (L), dead bacteria (D), EPS (E), the concentration of QS molecules (H) and  
the concentration of the growth factor (Q) in biofilms from donor 1 after 10 min CHX 
treatment as an example. Despite that the percentage of live bacteria continues to 
decrease as the result of a drastic increase in dead bacteria in the first week after the 
treatment (Fig 2&3), the volume fraction of live bacteria increases along with the 
growth factor right after the treatment (Fig 5 A&B). In this example, the results show 
that the EPS volume fraction reaches a plateau before the treatment even begins and is 
therefore less sensitive to the QS molecule and residual antibacterial agents after the 
treatment (Fig 5 A&B). As a comparison, we also plot the corresponding variables in 
the control group, labelled as untreated group. It shows clearly the live and dead 
bacteria eventually return to the level in the control group, while the QS molecule and 
the growth factor concentration never fully recover at the end of the simulation.  
 
We also examine time evolution of the aforementioned biofilm components from 
the responses of different aged biofilms to 3 min CHX treatment (Fig 5 C&D). The 
residual volume fractions of L, D and E right after the antibacterial treatment vary 
little for mature biofilms older than 21 days right after treatment, which means that 
16 
 
the effectiveness of bacterial killing by the antibacterial agents saturates with respect 
to the mature biofilms. Despite of the lack of efficiency in killing live bacteria in 
mature biofilms,  the QS molecule and growth factor continues to grow to sustain the 
recovery of the biofilms. As a comparison, the solutions from the control group are 
also plotted in Fig 5 C&D. We observe that the 3 min antibacterial treatment does 
have a sizable impact on the live and dead bacteria for all aged biofilms and the 
reduction in live bacteria and increase in dead bacteria right after the 3 mins treatment 
for mature biofilms are indeed insensitive to the age for older biofilms (older than 21 
days).  
 
 
Figure 5. (A) and (B): Time evolution of volume fractions of live bacteria (L), dead 
bacteria (D), EPS (E), concentrations of QS molecules (H) and growth factor (Q) in 
the biofilm model without treatment and after 10 min CHX treatment for donor 1 in 
the experiment. The QS molecule and growth factor level in treated biofilms are lower 
than those in the control group, shown in (B). (C) and (D): The same set of selected 
variables predicted by the model without treatment and right after the 3 min CHX 
treatment with respect to biofilms of different age groups taken from [22]. The time 
axis in (C) and (D) indicates the age of the biofilm. All the quantities plotted on the 
curves are the solutions of the model right after the 3 min antibacterial treatment with 
the initiation condition taken from the control group (i.e., the untreated biofilm). The 
corresponding solutions from the control group are also plotted for comparison. In (C), 
volume fractions of live, dead bacteria and EPS saturate among the older biofilms for 
both the treated and the control group. The 3 min treatment induces negligibly small 
changes in concentrations of QS molecules and growth factor, shown in (D). 
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Discussion 
 
Guided by the experiments, we have developed a quantitative model to describe 
biofilm recovery after antibacterial treatment. The multispecies oral biofilms grew out 
of the pooled plaque from two different donors showed nearly no difference in their 
susceptibility to all antibacterial agents, indicating a lack of variability in sensitivity 
from different sources of biofilms. The model can fit experimental observations well 
through a parameter calibration procedure. Although we coarse-grain the bacteria into 
only two gross types in the model for simplicity, the model can reproduce the 
recovery process very well for the given experimental data set. Study by Stojicic et al. 
6
 using multispecies biofilms grown on collagen-coated hydroxyapatite disks from 
different donors showed that biofilms from 6 different sources had a similar, 
time-dependent susceptibility pattern. Later, Yang et al
20
. using an infected dentin 
model also found that the multispecies biofilms from different donors showed similar 
susceptibility. The current study shows the same pattern of biofilm recovery after 
exposure to antibacterial agents in all biofilms taken from different donors. The 
present study further supports that the source and possible differences in the species 
composition of the multispecies biofilm have less impact on its susceptibility. To our 
knowledge, this is the first time the effect of the source of biofilms recovery is 
investigated. The results clearly indicate that the time needed for biofilms to recover 
is less dependent on the type of bacteria present in the biofilm. 
 
NaOCl, CHX, and IPI were chosen for the study because they are common 
endodontic irrigants and have different mechanisms in antibacterial treatment. NaOCl 
attacks microbe’s heat shock proteins causing the bacteria to form clumps and to die 
eventually 
21
. CHX reacts with bacterial cellular membrane 
22
 or causes the 
precipitation of the cytoplasmic contents 
23
. The mechanism of IPI involves multiple 
cellular effects by binding to proteins, nucleotides, and fatty acids
24
. CHX and IPI are 
less effective against biofilms than NaOCl. Post-antibiotic effect (PAE) is the 
continued suppression of bacterial growth after exposure of the bacteria to an 
antibacterial agent and removal of this agent from the environment 
25-27
. Proposed 
mechanisms by which the PAE occurs include both nonlethal damage induced by the 
antibacterial agent and a limited persistence of the antibacterial agent at the bacterial 
binding site. Factors that affect the duration of the PAE include 
microorganism-antibacterial combination, duration of antibacterial agent’s exposure, 
bacterial species, culture medium and experimental conditions. Interestingly, all 
irrigants have been shown to exhibit extended residual activity after treatment.  
 
The new quantitative model developed in this study simplifies a previous model 
and even yields an improved fitting to the experimental data 
14
. In this model, we 
group all unknown functional molecules/proteins into a single growth factor, which is 
a crucially important factor on bacterial growth and dynamics of QS molecules. 
Meanwhile, we assume dynamics of the growth factor is governed by the live bacteria 
and limited by its carrying capacity Qmax in the model. The treatment of biofilms by 
the antibacterial agents does not show any significant effect on the growth factor, 
except that its growth right after the treatment is much slower than that at a later time. 
Interestingly, the tamed growth in the growth factor during the first week still fuels 
the volume fraction of live bacteria to increase rather than decrease despite that its 
absolute population is low. The population of dead bacteria increases initially after the 
treatment as expected. The overall ratio of live vs total bacteria predicted by the 
18 
 
model matches the experimental data very well.  The model fitting the recovery 
curves demonstrates the key role played by the growth factor on time evolution of the 
biofilms. Although QS molecules remain a steady increase after the treatment, they 
don’t have any significant effect on the volume fraction of EPS in the biofilm overall. 
We have also experimented with other modeling approaches without the direct impact 
of the growth factor to bacterial growth without a success, which adds credibility to 
our current modeling approach.  
 
The mathematical model is used to describe biofilms from various donors and 
being treated by various antibacterial solutions. Its sensitivity on model parameters is 
therefore very important. We combine the control group and treated biofilm data to 
develop a general parameter calibration protocol, by which we classify the model 
parameters into three classes: (I) donor-independent parameters: (II) donor-dependent 
parameters; (III) antibacterial agent specific parameters. We have demonstrated in this 
study that the model prediction fits quite well to the experimental data. So the 
parameters in class (I) have no relations with the donors and the antibacterial agents. 
They are constants in the model. Among the donor and antibacterial agent dependent 
parameters, our study shows that their fluctuations with respect to different donors 
and antibacterial agents are minimal. When the model is applied to a completely 
different data set from a previous experiment for studying biofilm dynamics right 
after antibacterial treatment of different aged biofilms, good results are obtained as 
well. For a mechanistic model for such a complex biological system, we believe that 
this model indeed captures the essence of the biofilm dynamics and can shed insight 
on investigating details in biofilm dynamics.   
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Appendix: Nondimensionalization 
 
    
Notice that L, D, E, T are dimensionless variables while A, H, Q are not. We need to 
nondimensionalize the dimensional variables and equations in order to analyze and 
compute the equations. We denote the characteristic time scale as 𝑡0, the common 
characteristic concentration as 𝐶 We choose C=8.24e-3 kg/m3 [31] and t0=1/s. We 
define the dimensionless parameters as follows:  
?̂? ≜
𝑡
𝑡0
, 𝑐2̂ ≜ 𝑐2𝑡0 , 𝑘?̂? ≜
𝑘𝑞
𝐶
, 𝑟𝑏?̂? ≜ 𝑟𝑏𝑠𝑡0 , 𝑐3̂ ≜ 𝑐3𝑡0𝐶 , 𝑟𝑑?̂? ≜ 𝑟𝑑𝑝𝑡0,  𝑘13̂ ≜
𝑘13
𝐶
, 
𝑐5̂ ≜ 𝑐5𝑡0, 𝑘9̂ ≜
𝑘9
𝐶
, ?̂? ≜
𝐴
𝐶
, 𝑐8̂ ≜ 𝑐8𝑡0,  𝑟?̂? ≜ 𝑟𝑎𝑡0, ?̂? ≜
𝐻
𝐶
, ?̂?  ≜
𝑄
𝐶
,  𝐻𝑚𝑎?̂?  ≜
𝐻𝑚𝑎𝑥
𝐶
,
𝑄𝑚𝑎?̂? ≜
𝑄𝑚𝑎𝑥
𝐶
， 𝑐?̂? ≜
𝑐𝑎
𝐶
𝑡0， 𝑘?̂? ≜
𝑘𝑞
𝐶
 , and 𝑐?̂? ≜
𝑐𝑞
𝐶
 𝑡0.   
Substituting these parameters into the equations (1)~(6), we obtain the dimensionless 
equations. If we drop the hat on the variables and the parameters, we recover the 
dimensionless equations in exactly the same form as the dimensional equations. 
 
 (1) 
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𝑑?̂?
 𝑑?̂?
= 𝑐2̂
?̂?2
?̂?2 + 𝑘𝑞2
(1 −
𝐿
𝐿𝑚𝑎𝑥
)𝐿 − 𝑟𝑏?̂?𝐿 − 𝑐3̂𝛾?̂?𝐿, 
 
 
 
 
𝑑𝐷
𝑑?̂?
= 𝑟𝑏?̂?𝐿 + 𝑐3̂𝛾?̂?𝐿 − 𝑟𝑑?̂?
𝑘13̂
𝑘13̂ + ?̂?
𝐷, (2) 
 
 
𝑑𝐸
𝑑?̂?
= (𝑐5̂𝐿
?̂?2
?̂?2 + 𝑘9̂
2 + 𝑟𝑑?̂?
𝑘13̂
𝑘13̂ + ?̂?
𝐷) (1 −
𝐸
𝐸𝑚𝑎𝑥
), (3) 
 
 
𝑑𝐴
𝑑?̂?
= −𝑐8̂?̂?𝐿 − 𝑟?̂??̂?, (4) 
 
 
𝑑𝐻
𝑑?̂?
= 𝑐?̂?
?̂?2
?̂?2 + 𝑘?̂?
2 𝐿 (1 −
?̂?
 𝐻𝑚𝑎?̂?
), (5) 
 
 
𝑑?̂?
𝑑?̂?
=  𝑐?̂?𝐿 (1 −
?̂?
𝑄𝑚𝑎?̂?
), (6) 
where  
 𝐿 + 𝐷 + 𝐸 + 𝑇 = 1, (7) 
 
 
𝛾 =
1
𝑇 +
𝐸
𝐷𝑝𝑟
2(𝑇 + 𝐸)
2 + (𝐿 + 𝐷)
. 
(8) 
After fitting the parameters from the dimensionless model, we can get the 
corresponding value in the experiment by perform the transform: 
 𝑡 ≜ ?̂?𝑡0, 𝑐2 ≜ 𝑐2̂/𝑡0 , 𝑘𝑞 ≜ 𝐶𝑘?̂? , 𝑟𝑏𝑠 ≜ 𝑟𝑏?̂?/𝑡0 , 𝑐3 ≜ 𝑐3̂/(𝑡0𝐶) , 𝑟𝑑𝑝 ≜ 𝑟𝑑?̂?/𝑡0, 
𝑘13 ≜ 𝐶𝑘13̂,  𝑐5 ≜ 𝑐5/̂𝑡0, 𝑘9 ≜ 𝐶𝑘9̂ , 𝐴 ≜ 𝐶?̂? , 𝑐8 ≜ 𝑐8̂/𝑡0,  𝑟𝑎 ≜ 𝑟?̂?/𝑡0, 𝐻 ≜ ?̂?𝐶,
𝑄 ≜ 𝐶?̂?, 𝐻𝑚𝑎𝑥 ≜ 𝐶𝐻𝑚𝑎?̂?  , 𝑄𝑚𝑎𝑥 ≜ 𝐶𝑄𝑚𝑎?̂?， 𝑐𝑎 ≜ 𝑐?̂?𝐶/𝑡0， 𝑘𝑞 ≜ 𝐶𝑘?̂? , and 𝑐𝑞 ≜
𝐶𝑐?̂?/ 𝑡0.  
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